If I only Have Osteopenia, Not Osteoporosis, Am I Okay? No, You're Still at Risk! | Felice Gersh, MD
Why It Matters
Because osteopenia accounts for the majority of hip fractures, an effective, microbiome‑based supplement could dramatically lower fracture incidence and healthcare costs for a large at‑risk population.
Key Takeaways
- •Osteopenia accounts for 54% of women's hip fractures
- •Bone Dia is a probiotic medical food targeting gut‑bone axis
- •Trial enrolled 286 peri‑menopausal women, treated for one year
- •Bone Dia cut hip bone loss by roughly 85% in high‑risk group
- •Probiotic blend uses fruit‑vegetable strains producing anti‑inflammatory compounds
Summary
The video explains that osteopenia, often perceived as a milder condition than osteoporosis, still carries substantial fracture risk, especially for women.
Data reveal that 54% of hip fractures in women occur in those with osteopenia, and a recent randomized, placebo‑controlled trial of 286 women within six years of menopause showed Bone Dia reduced hip bone loss by about 85% in the highest‑risk participants.
Dr. Gersh describes Bone Dia as a “symbiotic medical food” containing four fruit‑and‑vegetable‑derived probiotic strains that act like “the Avengers,” producing anti‑inflammatory compounds via the gut‑bone axis.
If validated, this probiotic approach could shift prevention strategies toward early nutritional interventions, offering a non‑pharmaceutical option for millions of women with osteopenia.
Comments
Want to join the conversation?
Loading comments...